Dr. Gregory Mathis Brunin, MD

Dr. Brunin practices at Rashid, Rice, Flynn, & Reilly Eye Associates in San Antonio, Texas.

Dr. Brunin's NPI, 1043579733, was assigned on May 15, 2012. Dr. Brunin graduated from Baylor College Of Medicine in 2012. Dr. Brunin holds Texas license R2066.

Dr. Brunin's primary practice is Rashid, Rice, Flynn, & Reilly Eye Associates, at 7550 I-10 W, San Antonio, TX 78229 in Bexar County. The practice phone is (210) 340-1212.

Dr. Brunin's primary practice is Rashid, Rice, Flynn, & Reilly Eye Associates in San Antonio, Texas. The medical group on file is UT Health Physicians. Dmand AI also links Dr. Brunin to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brunin practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Brunin's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Brunin is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Brunin's licenses on file in 2 states: Texas and Colorado.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Brunin treats.

CMS data shows 4,989 Medicare services from Dr. Brunin across 23 procedure codes in 2024, for 1,774 Medicare patients. Medicare paid $425,234 for them.

CMS counts 1,774 Medicare patients who saw Dr. Brunin in 2024. The largest group is 75 to 84, with 791 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brunin's median patient age at 75, with 60% women.

In 2024, Dr. Brunin wrote 3,495 Medicare Part D claims for 971 patients. 60% of them were for generic drugs. CMS names the drug for 3,402 of them, across 24 drugs with 11 or more claims each, at $277,745 in total drug cost. In 2023, CMS named 2,773 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Brunin for performance year 2024, reported as part of a group. Dr. Brunin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 422 procedures of cataract surgery by Dr. Brunin, more than 93% of the clinicians it reports for that procedure.

Dmand AI links Dr. Brunin to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include Dry Eye Syndromes, Lacrimal Apparatus Diseases and Cataract. Surface Ophthalmics, Inc. sponsors the most, 2. Open Payments lists research payments to Dr. Brunin that name 1 trial.

CMS Open Payments shows 108 general payments to Dr. Brunin from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 85% of the total. RxSight Inc paid the most, $18,737. It also lists 1 research payment totaling $2,000 in 2020, naming 1 clinical trial.

Dr. Brunin graduated from Baylor College Of Medicine in 2012.

Dr. Brunin is in network with 20 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.